BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
TGFB1
,
glucose metabolic process
,
Inflammatory disorder
,
Kidney
,
Nosology
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
T-cells
(tissue)
Summary
General Info
Body Atlas
Curated Studies
Most Correlated Studies
SP3 knockdown in Jurkat cells
Thymocyte populations expression profiles
ETV6 inactivation in immature T-ALL cell line LOUCY
Dominant Th2 differentiation of regulatory T cells upon loss of FOXP3 expression
Acute lymphoblastic leukemia expression profiles of different karyotypic subtypes
Explore Curated Studies Results
Literature
Most Relevant Literature
Stress exhausts T cells.
Re-centauring T cell antigen discovery around CD4+ T cells.
Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (I…
The Functional Assessment of T Cells.
Selective STING stimulation in dendritic cells primes antitumor T cell responses.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies
CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies
CAR-37 T Cells In Hematologic Malignancies
LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T-cell Lymphoma
Study of Base Edited CAR7 T Cells to Treat T Cell Malignancies (TvT CAR7)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ